NO309091B1 - Oksazolidinonderivater, deres fremstilling samt medikament og farmasøytisk preparat inneholdende disse - Google Patents

Oksazolidinonderivater, deres fremstilling samt medikament og farmasøytisk preparat inneholdende disse Download PDF

Info

Publication number
NO309091B1
NO309091B1 NO975530A NO975530A NO309091B1 NO 309091 B1 NO309091 B1 NO 309091B1 NO 975530 A NO975530 A NO 975530A NO 975530 A NO975530 A NO 975530A NO 309091 B1 NO309091 B1 NO 309091B1
Authority
NO
Norway
Prior art keywords
group
formula
compound
hydrogen atom
atom
Prior art date
Application number
NO975530A
Other languages
English (en)
Norwegian (no)
Other versions
NO975530D0 (no
NO975530L (no
Inventor
Samir Jegham
Frederic Puech
Philippe Burnier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO309091(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr
Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO975530D0 publication Critical patent/NO975530D0/no
Publication of NO975530L publication Critical patent/NO975530L/no
Publication of NO309091B1 publication Critical patent/NO309091B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO975530A 1995-06-02 1997-12-01 Oksazolidinonderivater, deres fremstilling samt medikament og farmasøytisk preparat inneholdende disse NO309091B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9506564A FR2734821B1 (fr) 1995-06-02 1995-06-02 Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506563A FR2734820B1 (fr) 1995-06-02 1995-06-02 Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
PCT/FR1996/000792 WO1996038444A1 (fr) 1995-06-02 1996-05-28 Derives d'oxazolidinone, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO975530D0 NO975530D0 (no) 1997-12-01
NO975530L NO975530L (no) 1998-02-02
NO309091B1 true NO309091B1 (no) 2000-12-11

Family

ID=26232004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975530A NO309091B1 (no) 1995-06-02 1997-12-01 Oksazolidinonderivater, deres fremstilling samt medikament og farmasøytisk preparat inneholdende disse

Country Status (26)

Country Link
US (1) US5843975A (cs)
EP (1) EP0835254B1 (cs)
JP (1) JP3856829B2 (cs)
KR (1) KR100457502B1 (cs)
CN (1) CN1075072C (cs)
AR (1) AR006301A1 (cs)
AT (1) ATE184005T1 (cs)
AU (1) AU699367B2 (cs)
BR (1) BR9608896A (cs)
CA (1) CA2223011C (cs)
CO (1) CO4700462A1 (cs)
CZ (1) CZ378497A3 (cs)
DE (1) DE69604071T2 (cs)
DK (1) DK0835254T3 (cs)
ES (1) ES2138346T3 (cs)
GR (1) GR3031710T3 (cs)
HU (1) HU224879B1 (cs)
MX (1) MX9709410A (cs)
NO (1) NO309091B1 (cs)
NZ (1) NZ310487A (cs)
PL (1) PL183919B1 (cs)
RU (1) RU2164226C2 (cs)
SK (1) SK281934B6 (cs)
TW (1) TW360654B (cs)
WO (1) WO1996038444A1 (cs)
ZA (1) ZA964563B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
CA2671776C (en) * 2001-01-31 2012-12-18 H. Lundbeck A/S Gal3 receptor antagonists for the treatment of depression
TWI248438B (en) * 2001-04-10 2006-02-01 Sod Conseils Rech Applic Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
BR0212841A (pt) * 2001-09-26 2004-08-03 Pharmacia Italia Spa Derivado ativo de aminoindazole como inibidores de cinase, processo para sua preparação e composições farmacêuticas que os contém
DE10334309A1 (de) * 2003-07-28 2005-03-03 Aventis Pharma Deutschland Gmbh Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
CA2637811A1 (en) * 2006-02-01 2007-08-09 Pfizer Products Inc. Benzisoxazole oxazolidinones as antibacterial agents
JPWO2008120655A1 (ja) * 2007-03-30 2010-07-15 株式会社医薬分子設計研究所 Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
EP2123159A1 (de) * 2008-05-21 2009-11-25 Bayer CropScience AG (1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
AU2010330894A1 (en) * 2009-12-18 2012-07-05 Janssen Pharmaceutica Nv Substituted aminothiazolone indazoles as estrogen related receptor-aalpha modulators
WO2011103130A1 (en) * 2010-02-17 2011-08-25 Janssen Pharmaceutica Nv Aminothiazolones as estrogen related receptor-alpha modulators
WO2016097355A1 (en) * 2014-12-19 2016-06-23 Ge Healthcare Limited Labelled oxazolidinone derivatives
DE102015012050A1 (de) * 2015-09-15 2017-03-16 Merck Patent Gmbh Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) * 2016-09-05 2017-12-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ) Иммунодепрессант

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
WO1992014418A1 (en) * 1991-02-20 1992-09-03 Yusaku Koda Articulator

Also Published As

Publication number Publication date
TW360654B (en) 1999-06-11
NZ310487A (en) 1999-05-28
CN1191534A (zh) 1998-08-26
BR9608896A (pt) 1999-06-29
ATE184005T1 (de) 1999-09-15
CA2223011C (en) 2007-01-09
PL183919B1 (pl) 2002-08-30
NO975530D0 (no) 1997-12-01
CA2223011A1 (en) 1996-12-05
ZA964563B (en) 1996-12-12
AR006301A1 (es) 1999-08-25
CN1075072C (zh) 2001-11-21
DK0835254T3 (da) 2000-03-27
KR100457502B1 (ko) 2005-09-05
US5843975A (en) 1998-12-01
AU699367B2 (en) 1998-12-03
KR19990022187A (ko) 1999-03-25
CO4700462A1 (es) 1998-12-29
EP0835254B1 (fr) 1999-09-01
WO1996038444A1 (fr) 1996-12-05
DE69604071D1 (de) 1999-10-07
HU224879B1 (en) 2006-03-28
HUP9901349A2 (hu) 1999-08-30
SK281934B6 (sk) 2001-09-11
HUP9901349A3 (en) 2000-02-28
JP3856829B2 (ja) 2006-12-13
AU6128896A (en) 1996-12-18
HK1014938A1 (en) 1999-10-08
CZ378497A3 (cs) 1998-04-15
GR3031710T3 (en) 2000-02-29
SK161497A3 (en) 1998-05-06
JPH11507330A (ja) 1999-06-29
DE69604071T2 (de) 2000-04-06
RU2164226C2 (ru) 2001-03-20
NO975530L (no) 1998-02-02
MX9709410A (es) 1998-07-31
EP0835254A1 (fr) 1998-04-15
PL323673A1 (en) 1998-04-14
ES2138346T3 (es) 2000-01-01

Similar Documents

Publication Publication Date Title
NO309091B1 (no) Oksazolidinonderivater, deres fremstilling samt medikament og farmasøytisk preparat inneholdende disse
CA2176668C (fr) Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
US5710152A (en) Benzoazine derivative or salt thereof and pharmaceutical compostion comprising the same
EP0433149B1 (fr) Antagonistes de la sérotonine, leur préparation et les médicaments les contenant
EP0350403A1 (fr) Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant
NO167916B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
US5504095A (en) Aminobenzosultam derivatives as lipoxygenase inhibitors
ES2197466T3 (es) Oxazolidinonas como antagonistas de 5ht2a.
JP2019520403A (ja) ベンゾ［ｄ］チアゾール誘導体またはその塩、およびそれを含む医薬組成物
EP0841330B1 (fr) Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
DK166584B1 (da) Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem
CA1231950A (fr) Procede d'obtention de nouveaux derives substitues du 2,5-diamino 1,4-diazole et des compositions pharmaceutiques en renfermant
HU203548B (en) Process for producing benzoxazine derivatives and pharmaceutical compositions containing them
JPH09504531A (ja) ５‐アリールイソキサゾール‐４‐イル‐置換された２‐アミノカルボン酸化合物
EP0891358A1 (fr) Composes derives d'oxazolidin-2-one, leur procede de preparation et leur application en therapeutique
KR19990030199A (ko) 크로멘 유도체 및 그의 염 그리고 이를 함유하는 의약
RU2017737C1 (ru) Способ получения изоксазоловых производных
FR2741071A1 (fr) Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2533212A1 (fr) Benzo-et thieno-triazine-1,2,3 ones-4 procedes de preparation et medicaments les contenant
FR2734820A1 (fr) Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2734821A1 (fr) Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2739856A1 (fr) Derives de 3-benzofuranyloxazolidin-2-one, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
MK1K Patent expired